iCell for Safety Pharmacology & Cytotoxicity Test

Safety pharmacology and toxicity testing are critical steps to ensure the safety and efficacy of new drugs. With the advancement of scientific technology, iPSCs have emerged as an innovative and effective alternative for these tests.

• Emulate Human Physiology: Accurately predict drug interactions within a human cellular context.

• Ensure Experimental Consistency: Leverage the reproducibility of iPSC-derived cells for reliable results.

• Minimize Animal Utilization: Substitute traditional animal models with human cell-based assays.

iCells International can perform a comprehensive suite of cell products derived from iPSCs, including cardiomyocytes and a variety of neuronal cell types. These cellular models play a crucial role at pivotal stages of drug development, particularly in assessing arrhythmias and neurotoxicity. Leveraging these advanced cellular systems, we are able to identify and predict potential toxic effects earlier in the drug development process, thereby enhancing the accuracy and efficiency of drug safety assessments.